.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Cerilliant
Baxter
Accenture
Novartis
Boehringer Ingelheim
Fuji
Farmers Insurance
McKinsey
Deloitte

Generated: December 14, 2017

DrugPatentWatch Database Preview

LOVENOX Drug Profile

« Back to Dashboard

Which patents cover Lovenox, and what generic alternatives are available?

Lovenox is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in LOVENOX is enoxaparin sodium. There are ten drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the enoxaparin sodium profile page.
Drug patent expirations by year for LOVENOX

Pharmacology for LOVENOX

Medical Subject Heading (MeSH) Categories for LOVENOX

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis UsLOVENOXenoxaparin sodiumINJECTABLE;INTRAVENOUS, SUBCUTANEOUS020164-009Jan 23, 2003ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsLOVENOX (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS020164-005Mar 27, 1998APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsLOVENOX (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS020164-003Mar 27, 1998APRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsLOVENOX (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS020164-007Jun 2, 2000APRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsLOVENOX (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS020164-001Mar 29, 1993APRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsLOVENOX (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS020164-002Jan 30, 1998APRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsLOVENOX (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS020164-006Jun 2, 2000DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsLOVENOX (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS020164-004Mar 27, 1998APRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsLOVENOX (PRESERVATIVE FREE)enoxaparin sodiumINJECTABLE;SUBCUTANEOUS020164-008Jun 2, 2000APRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LOVENOX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis UsLOVENOXenoxaparin sodiumINJECTABLE;INTRAVENOUS, SUBCUTANEOUS020164-009Jan 23, 2003► Subscribe► Subscribe
Sanofi Aventis UsLOVENOXenoxaparin sodiumINJECTABLE;INTRAVENOUS, SUBCUTANEOUS020164-009Jan 23, 2003► Subscribe► Subscribe
Sanofi Aventis UsLOVENOXenoxaparin sodiumINJECTABLE;INTRAVENOUS, SUBCUTANEOUS020164-009Jan 23, 2003► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for LOVENOX

Drugname Dosage Strength RLD Submissiondate
enoxaparin sodiumInjection100 mg/mL, 3 mL vialsLovenox12/7/2006

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Farmers Insurance
Deloitte
Moodys
Daiichi Sankyo
Covington
QuintilesIMS
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot